Clinical Trial Update: Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the Impella LP 2.5 System in patients with acute myocardial infarction and hemodynamic instability was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Impella LP 2.5 System

Snippet

Sponsor: Abiomed Inc. | Conditions: Acute Myocardial Infarction | Phase 3 | Status: TERMINATED